{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:25:09Z","timestamp":1789593909551,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ijrobp.2022.03.005","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T21:52:42Z","timestamp":1647467562000},"page":"732-741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 Trial"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2312-5418","authenticated-orcid":false,"given":"Bradford S.","family":"Hoppe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romaine C.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Flampouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Pankuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dat C.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranshu","family":"Mohindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Hartsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasiruddin","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Chon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry L.","family":"Kestin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.03.005_bib0001","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0360-3016(86)90061-1","article-title":"Impact of tumor control on survival in carcinoma of the lung treated with irradiation","volume":"12","author":"Perez","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0002","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.19.01162","article-title":"Long-term results of NRG oncology RTOG 0617: Standard- versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer","volume":"38","author":"Bradley","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0003","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijrobp.2018.01.046","article-title":"Phase 1 study of accelerated hypofractionated radiation therapy with concurrent chemotherapy for stage III non-small cell lung cancer: CALGB 31102 (Alliance)","volume":"101","author":"Urbanic","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0004","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1053\/j.seminoncol.2005.03.004","article-title":"Pilot study of accelerated radiotherapy with concurrent chemotherapy for stage III non-small cell lung cancer","volume":"32","author":"Machtay","year":"2005","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7785\/tcrt.2012.500208","article-title":"Protons safely allow coverage of high-risk nodes for patients with regionally advanced non-small-cell lung cancer","volume":"10","author":"Nichols","year":"2011","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0006","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijrobp.2006.01.052","article-title":"Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in stage I or stage III non-small-cell lung cancer","volume":"65","author":"Chang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0007","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.meddos.2021.07.003","article-title":"A Planning comparison of IMRT vs. pencil beam scanning for deep inspiration breath hold lung cancers","volume":"47","author":"Mah","year":"2022","journal-title":"Med Dosim"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0008","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ijrobp.2013.03.035","article-title":"Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer","volume":"86","author":"Gomez","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0009","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13014-016-0640-8","article-title":"Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: Phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC","volume":"11","author":"Giaddui","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0010","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cllc.2011.11.008","article-title":"Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results","volume":"13","author":"Hoppe","year":"2012","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0011","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0012","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1200\/JCO.2010.33.4979","article-title":"Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407","volume":"29","author":"Govindan","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0013","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0014","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijrobp.2010.09.004","article-title":"Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: An analysis of the Radiation Therapy Oncology Group","volume":"82","author":"Machtay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0015","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1200\/JCO.2009.27.1205","article-title":"Primary analysis of the phase II component of a phase I\/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117","volume":"28","author":"Bradley","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0016","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijrobp.2020.03.015","article-title":"Hypofractionated Proton Therapy with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Trial from the University of Florida and Proton Collaborative Group","volume":"107","author":"Hoppe","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0017","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cllc.2014.08.002","article-title":"Radical-intent hypofractionated radiotherapy for locally advanced non-small-cell lung cancer: a systematic review of the literature","volume":"16","author":"Kaster","year":"2015","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0018","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.radonc.2020.04.033","article-title":"Accelerated hypofractionated radiotherapy with concurrent full dose chemotherapy for locally advanced non-small cell lung cancer: A phase I\/II study","volume":"148","author":"Glinski","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0019","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.prro.2021.06.004","article-title":"Hypofractionated intensity modulated radiation therapy with concurrent chemotherapy in locally advanced non-small cell lung cancer: A phase II prospective clinical trial (GASTO1011)","volume":"11","author":"Qiu","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12885-016-2314-1","article-title":"Accelerated hypofractionated three-dimensional conformal radiation therapy (3 Gy\/fraction) combined with concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer: preliminary results of an early terminated phase II trial","volume":"16","author":"Ren","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0021","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1200\/JCO.2017.74.0720","article-title":"Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non-small-cell lung cancer","volume":"36","author":"Liao","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.2032","article-title":"Proton beam radiotherapy and concurrent chemotherapy for unresectable stage III non-small cell lung cancer: Final results of a phase 2 study","volume":"3","author":"Chang","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0023","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijrobp.2009.04.028","volume":"77","author":"Zhang","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0024","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jtho.2020.10.013","article-title":"Toxicity and survival after intensity-modulated proton therapy versus passive scattering proton therapy for NSCLC","volume":"16","author":"Gjyshi","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijrobp.2017.05.014","article-title":"Consensus guidelines for implementing pencil-beam scanning proton therapy for thoracic malignancies on behalf of the PTCOG thoracic and lymphoma subcommittee","volume":"99","author":"Chang","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0026","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1120\/jacmp.v16i6.5678","article-title":"Beam-specific planning target volumes incorporating 4D CT for pencil beam scanning proton therapy of thoracic tumors","volume":"16","author":"Lin","year":"2015","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0027","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijrobp.2015.11.004","article-title":"A Phase 2 Trial of Concurrent Chemotherapy and Proton Therapy for Stage III Non-Small Cell Lung Cancer: Results and Reflections Following Early Closure of a Single-Institution Study","volume":"95","author":"Hoppe","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0028","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jnci\/djr325","article-title":"Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410","volume":"103","author":"Curran","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2022.03.005_bib0029","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cllc.2017.03.007","article-title":"Enrollment of elderly patients with locally advanced non-small cell lung cancer in multi-institutional trials of proton beam radiation therapy","volume":"18","author":"Verma","year":"2017","journal-title":"Clin Lung Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622002383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622002383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:59:53Z","timestamp":1759744793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622002383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0360301622002383"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.03.005","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}